Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
71,858,757
-
Number of holders
-
2
-
Total 13F shares, excl. options
-
3,034,321
-
Shares change
-
-11,800,052
-
Total reported value, excl. options
-
$336,038,595
-
Value change
-
-$76,346,336
-
Number of sells
-
-2
-
Price
-
$64.66
Significant Holders of SINOVAC BIOTECH LTD. - Common Shares (SVA) as of Q4 2024
4 filings reported holding SVA - SINOVAC BIOTECH LTD. - Common Shares as of Q4 2024.
SINOVAC BIOTECH LTD. - Common Shares (SVA) has 2 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,034,321 shares
of 71,858,757 outstanding shares and own 4.2% of the company stock.
Largest 4 shareholders include ORBIMED ADVISORS LLC (2,718,735 shares), Neumann Advisory Hong Kong Ltd (315,586 shares), Horizon Investments, LLC (0 shares), and Vivo Capital, LLC (0 shares).
This table shows the top 2 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.